全球伴侣动物药品市场规模、份额、趋势和成长分析报告（2026-2034）

预计伴侣动物药品市场将从 2025 年的 203.7 亿美元成长到 2034 年的 360.6 亿美元，2026 年至 2034 年的复合年增长率为 6.55%。

受宠物饲养量增加和人们对动物健康与福祉意识不断提高的推动，伴侣动物药品市场正经历显着增长。随着越来越多的家庭将宠物视为家庭成员，对兽医服务和产品的需求也随之激增。宠物饲主越来越积极寻求预防性护理，从而扩大了疫苗、诊断和治疗产品的市场。这一趋势在宠物饲养率高的地区尤其明显，显示消费者愿意为动物健康和福利进行投资。随着市场的不断发展，兽医学和技术的创新有望提升伴侣动物医疗保健的品质。

此外，宠物日益人性化正在对伴侣动物药品市场产生重大影响。随着宠物越来越被视为家庭成员，饲主也开始寻求与人类同等的高品质医疗保健服务。这种转变推动了对先进疗法的需求，包括针对伴侣动物特定需求的专科手术、牙科护理和营养补充剂。此外，远端医疗的日益普及也让饲主更容易获得专家建议和服务，进一步扩大了市场。随着人们对宠物健康和福祉的关注度不断提高，伴侣动物医疗保健市场预计将持续成长，以满足饲主不断变化的需求。

此外，研发领域的进步正在推动伴侣动物药品市场的发展。新药、生物製药和诊断工具的出现，提高了诊断和治疗各种宠物疾病的能力。随着兽医专业人员获得更多有效的治疗方案，伴侣动物的整体护理品质有望得到提升。此外，兽医专业人员与宠物产品製造商之间日益紧密的合作正在推动市场创新，并促成新型有效解决方案的开发。随着伴侣动物药品市场的不断发展，在对高品质兽医护理需求不断增长的推动下，预计将保持持续增长。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球伴侣动物药品市场：依适应症划分

• 市场分析、洞察与预测
• 感染疾病
• 皮肤病（皮肤病）
• 疼痛
• 整形外科疾病
• 行为障碍
• 其他（牙科、心臟、怀孕、癌症）

第五章 全球伴侣动物药品市场：依给药途径划分

• 市场分析、洞察与预测
• 口服
• 注射药物
• 局部行政部门

第六章 全球伴侣动物药品市场：依动物类型划分

• 市场分析、洞察与预测
• 狗
• 猫
• 马
• 其他伴侣动物

第七章 全球伴侣动物药品市场：依通路划分

• 市场分析、洞察与预测
• 动物医院
• 动物诊所
• 零售药房

第八章 全球伴侣动物药品市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第九章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第十章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Zoetis
  • Merck Animal Health
  • Boehringer Ingelheim Animal Health
  • Elanco Animal Health
  • Ceva SantAfA（C）Animale
  • Virbac
  • Dechra Pharmaceuticals
  • Vetoquinol
  • Neogen Corporation
  • Orion Group
  • Norbrook Holdings
  • Chanelle Pharma
  • HIPRA
  • Kyoritsu Seiyaku
  • BiogAfA（C）NAfA（C）Sis BagAfA3

The Companion Animal Medicine Market size is expected to reach USD 36.06 Billion in 2034 from USD 20.37 Billion (2025) growing at a CAGR of 6.55% during 2026-2034.

The companion animal medicine market is experiencing significant growth, driven by the increasing pet ownership and the rising awareness of animal health and wellness. As more households welcome pets into their lives, the demand for veterinary services and products is surging. Pet owners are becoming more proactive in seeking preventive care, leading to a growing market for vaccines, diagnostics, and therapeutic treatments. This trend is particularly pronounced in regions with high pet ownership rates, where consumers are willing to invest in the health and well-being of their animals. As the market continues to evolve, innovations in veterinary medicine and technology are expected to enhance the quality of care available for companion animals.

Moreover, the growing trend of pet humanization is significantly influencing the companion animal medicine market. As pets are increasingly viewed as family members, owners are seeking high-quality medical care that mirrors human healthcare standards. This shift is driving demand for advanced treatments, including specialized surgeries, dental care, and nutritional supplements tailored to the unique needs of companion animals. Additionally, the rise of telemedicine in veterinary care is making it easier for pet owners to access professional advice and services, further expanding the market. As the focus on pet health and wellness continues to grow, the companion animal medicine market is expected to thrive, catering to the evolving needs of pet owners.

Furthermore, advancements in research and development are enhancing the companion animal medicine market. The emergence of new pharmaceuticals, biologics, and diagnostic tools is improving the ability to diagnose and treat various conditions in pets. As veterinary professionals gain access to more effective treatment options, the overall quality of care for companion animals is expected to improve. Additionally, the increasing collaboration between veterinary professionals and pet product manufacturers is fostering innovation in the market, leading to the development of new and effective solutions. As the companion animal medicine market continues to evolve, it is likely to witness sustained growth, driven by the increasing demand for high-quality veterinary care.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Indication

• Infectious Diseases
• Dermatologic Diseases (Skin Diseases)
• Pain
• Orthopedic Diseases
• Behavioral Disorders
• Others (Dental, Cardio, Pregnancy, Cancer)

By Route of Administration

• Oral
• Injectable
• Topical

By Animal Type

• Dogs
• Cats
• Horses
• Other Companion Animals

By Distribution Channel

• Veterinary Hospitals
• Veterinary Clinics
• Retail Pharmacies

COMPANIES PROFILED

• Zoetis, Merck Animal Health, Boehringer Ingelheim Animal Health, Elanco Animal Health, Ceva Sant Animale, Virbac, Dechra Pharmaceuticals, Vetoquinol, Neogen Corporation, Orion Group, Norbrook Holdings, Chanelle Pharma, HIPRA, Kyoritsu Seiyaku, Biognsis Bag

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL COMPANION ANIMAL MEDICINE MARKET: BY INDICATION 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Indication
• 4.2. Infectious Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Dermatologic Diseases (Skin Diseases) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Pain Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Orthopedic Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Behavioral Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Others (Dental, Cardio, Pregnancy, Cancer) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL COMPANION ANIMAL MEDICINE MARKET: BY ROUTE OF ADMINISTRATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Route Of Administration
• 5.2. Oral Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Injectable Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Topical Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL COMPANION ANIMAL MEDICINE MARKET: BY ANIMAL TYPE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Animal Type
• 6.2. Dogs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Cats Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Horses Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Other Companion Animals Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL COMPANION ANIMAL MEDICINE MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Distribution Channel
• 7.2. Veterinary Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Veterinary Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Retail Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL COMPANION ANIMAL MEDICINE MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Indication
  • 8.2.2 By Route Of Administration
  • 8.2.3 By Animal Type
  • 8.2.4 By Distribution Channel
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Indication
  • 8.3.2 By Route Of Administration
  • 8.3.3 By Animal Type
  • 8.3.4 By Distribution Channel
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Indication
  • 8.4.2 By Route Of Administration
  • 8.4.3 By Animal Type
  • 8.4.4 By Distribution Channel
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Indication
  • 8.5.2 By Route Of Administration
  • 8.5.3 By Animal Type
  • 8.5.4 By Distribution Channel
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Indication
  • 8.6.2 By Route Of Administration
  • 8.6.3 By Animal Type
  • 8.6.4 By Distribution Channel
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL COMPANION ANIMAL MEDICINE INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Zoetis
  • 10.2.2 Merck Animal Health
  • 10.2.3 Boehringer Ingelheim Animal Health
  • 10.2.4 Elanco Animal Health
  • 10.2.5 Ceva SantAfA(C) Animale
  • 10.2.6 Virbac
  • 10.2.7 Dechra Pharmaceuticals
  • 10.2.8 Vetoquinol
  • 10.2.9 Neogen Corporation
  • 10.2.10 Orion Group
  • 10.2.11 Norbrook Holdings
  • 10.2.12 Chanelle Pharma
  • 10.2.13 HIPRA
  • 10.2.14 Kyoritsu Seiyaku
  • 10.2.15 BiogAfA(C)NAfA(C)Sis BagAfA3